🔗 Visit the ClinicalTrials.gov page for NCT00122486
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial. | PLoS Clin Trials | 2007 | 4.93 |
| 2 | HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal. | PLoS One | 2011 | 0.78 |
| 3 | Role of the pharmacist in pre-exposure chemoprophylaxis (PrEP) therapy for HIV prevention. | Pharm Pract (Granada) | 2009 | 0.78 |